While different immunomodulating compounds like IL-2 were used to restore CD4 + T cell count in HIV infection, they failed to reduce the incidence of opportunistic disease or death because the expanded CD4 + T cells lacked host defense capacity. This evidence concerns the gene CD4 and HIV infectious disease.